| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acid-switchable nanoparticles induce self-adaptive aggregation for enhancing antitumor immunity of natural killer cells
|
Sun, Xiangshi
|
|
|
|
7 |
p. 3093-3105
|
artikel
|
| 2 |
Activating Connexin43 gap junctions primes adipose tissue for therapeutic intervention
|
Zhu, Yi
|
|
|
|
7 |
p. 3063-3072
|
artikel
|
| 3 |
Activation of insulin-like growth factor-1 receptor (IGF-1R) promotes growth of colorectal cancer through triggering the MEX3A-mediated degradation of RIG-I
|
Xie, Qiaobo
|
|
|
|
7 |
p. 2963-2975
|
artikel
|
| 4 |
A micro-sized vaccine based on recombinant Lactiplantibacillus plantarum fights against SARS-CoV-2 infection via intranasal immunization
|
Li, Letian
|
|
|
|
7 |
p. 3168-3176
|
artikel
|
| 5 |
Analysis on herbal medicines utilized for treatment of COVID-19
|
Luo, Lu
|
|
|
|
7 |
p. 1192-1204
|
artikel
|
| 6 |
AncPhore: A versatile tool for anchor pharmacophore steered drug discovery with applications in discovery of new inhibitors targeting metallo-β-lactamases and indoleamine/tryptophan 2,3-dioxygenases
|
Dai, Qingqing
|
|
|
|
7 |
p. 1931-1946
|
artikel
|
| 7 |
A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy
|
Sun, Luchen
|
|
|
|
7 |
p. 3027-3042
|
artikel
|
| 8 |
A novel PGAM5 inhibitor LFHP-1c protects blood–brain barrier integrity in ischemic stroke
|
Gao, Chenglong
|
|
|
|
7 |
p. 1867-1884
|
artikel
|
| 9 |
Application of microfluidic technologies on COVID-19 diagnosis and drug discovery
|
Lin, Zhun
|
|
|
|
7 |
p. 2877-2896
|
artikel
|
| 10 |
A rationally designed cancer vaccine based on NIR-II fluorescence image-guided light-triggered remote control of antigen cross-presentation and autophagy
|
Wu, Aihua
|
|
|
|
7 |
p. 3121-3136
|
artikel
|
| 11 |
A redox-responsive self-assembling COA-4-arm PEG prodrug nanosystem for dual drug delivery suppresses cancer metastasis and drug resistance by downregulating hsp90 expression
|
Zhou, Yi
|
|
|
|
7 |
p. 3153-3167
|
artikel
|
| 12 |
Author correction to “DNA damage repair promotion in colonic epithelial cells by andrographolide downregulated cGAS‒STING pathway activation and contributed to the relief of CPT-11-induced intestinal mucositis” [Acta Pharmaceutica Sinica B 12 (2022) 262–273]
|
Wang, Yuanyuan
|
|
|
|
7 |
p. 3177
|
artikel
|
| 13 |
Author correction to ‘Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling’ [Acta Pharmaceutica Sinica B 12 (2022) 1198–1212]
|
Wu, Yunhao
|
|
|
|
7 |
p. 3198-3199
|
artikel
|
| 14 |
Author correction to “YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer” [Acta Pharmaceutica Sinica B 12 (2022) 2845–2858]
|
Lai, Fangfang
|
|
|
|
7 |
p. 3178-3179
|
artikel
|
| 15 |
Bioactive natural compounds against human coronaviruses: a review and perspective
|
Xian, Yanfang
|
|
|
|
7 |
p. 1163-1174
|
artikel
|
| 16 |
Biological fate and interaction with cytochromes P450 of the nanocarrier material, d-α-tocopheryl polyethylene glycol 1000 succinate
|
Ren, Tianming
|
|
|
|
7 |
p. 3156-3166
|
artikel
|
| 17 |
Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects
|
Masoumi, Javad
|
|
|
|
7 |
p. 1721-1739
|
artikel
|
| 18 |
Coating with flexible DNA network enhanced T-cell activation and tumor killing for adoptive cell therapy
|
Zhang, Ziyan
|
|
|
|
7 |
p. 1965-1977
|
artikel
|
| 19 |
Combating COVID-19 with integrated traditional Chinese and Western medicine in China
|
Ni, Liqiang
|
|
|
|
7 |
p. 1149-1162
|
artikel
|
| 20 |
Controlling antifungal activity with light: Optical regulation of fungal ergosterol biosynthetic pathway with photo-responsive CYP51 inhibitors
|
Li, Zhuang
|
|
|
|
7 |
p. 3080-3092
|
artikel
|
| 21 |
Cover Story
|
|
|
|
|
7 |
p. viii
|
artikel
|
| 22 |
Cover Story
|
|
|
|
|
7 |
p. ix
|
artikel
|
| 23 |
Cover Story
|
|
|
|
|
7 |
p. ix
|
artikel
|
| 24 |
Cover Story
|
|
|
|
|
7 |
p. ix
|
artikel
|
| 25 |
Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites
|
Kang, Sisi
|
|
|
|
7 |
p. 1228-1238
|
artikel
|
| 26 |
Current approaches of nanomedicines in the market and various stage of clinical translation
|
Shan, Xiaoting
|
|
|
|
7 |
p. 3028-3048
|
artikel
|
| 27 |
Design of drug-like hepsin inhibitors against prostate cancer and kidney stones
|
Blay, Vincent
|
|
|
|
7 |
p. 1309-1320
|
artikel
|
| 28 |
Deubiquitination complex platform: A plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes
|
Fang, Yi-Zheng
|
|
|
|
7 |
p. 2955-2962
|
artikel
|
| 29 |
Discovery of 4-arylthiophene-3-carboxylic acid as inhibitor of ANO1 and its effect as analgesic agent
|
Wang, Yuxi
|
|
|
|
7 |
p. 1947-1964
|
artikel
|
| 30 |
3D organoids derived from the small intestine: An emerging tool for drug transport research
|
Zhang, Yuanjin
|
|
|
|
7 |
p. 1697-1707
|
artikel
|
| 31 |
Dose selection of chloroquine phosphate for treatment of COVID-19 based on a physiologically based pharmacokinetic model
|
Cui, Cheng
|
|
|
|
7 |
p. 1216-1227
|
artikel
|
| 32 |
D3Targets-2019-nCoV: a webserver for predicting drug targets and for multi-target and multi-site based virtual screening against COVID-19
|
Shi, Yulong
|
|
|
|
7 |
p. 1239-1248
|
artikel
|
| 33 |
Editorial of Special Column “Research on Emerging COVID-19 (Target, Mechanism, and Therapeutics)”
|
Luo, Hai-Bin
|
|
|
|
7 |
p. 1146-1148
|
artikel
|
| 34 |
Editor Profiles: Guest Editors of Special Column “Research on Emerging COVID-19 (Target, Mechanism, and Therapeutics)”
|
|
|
|
|
7 |
p. 1145
|
artikel
|
| 35 |
Efficient drug and gene delivery to liver fibrosis: rationale, recent advances, and perspectives
|
Mahdinloo, Somayeh
|
|
|
|
7 |
p. 1279-1293
|
artikel
|
| 36 |
Emerging roles of Aurora-A kinase in cancer therapy resistance
|
Zheng, Dayong
|
|
|
|
7 |
p. 2826-2843
|
artikel
|
| 37 |
Engineering prodrug nanomicelles as pyroptosis inducer for codelivery of PI3K/mTOR and CDK inhibitors to enhance antitumor immunity
|
Yang, Qichao
|
|
|
|
7 |
p. 3139-3155
|
artikel
|
| 38 |
Enzyme-instructed hybrid nanogel/nanofiber oligopeptide hydrogel for localized protein delivery
|
Jiang, Tianyue
|
|
|
|
7 |
p. 2070-2079
|
artikel
|
| 39 |
Erratum to “Identification of anti-Mycobacterium tuberculosis agents targeting the interaction of bacterial division proteins FtsZ and SepFe” [Acta Pharmaceutica Sinica B 13 (2023) 2056–2070]
|
Zhang, Hongjuan
|
|
|
|
7 |
p. 3180
|
artikel
|
| 40 |
Evaluation of 124I-JS001 for hPD1 immuno-PET imaging using sarcoma cell homografts in humanized mice
|
Huang, Haifeng
|
|
|
|
7 |
p. 1321-1330
|
artikel
|
| 41 |
Evodiamine-inspired dual inhibitors of histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) with potent antitumor activity
|
Huang, Yahui
|
|
|
|
7 |
p. 1294-1308
|
artikel
|
| 42 |
Evolution and development of potent monobactam sulfonate candidate IMBZ18g as a dual inhibitor against MDR Gram-negative bacteria producing ESBLs
|
Li, Zhiwen
|
|
|
|
7 |
p. 3067-3079
|
artikel
|
| 43 |
Generation of αGal-enhanced bifunctional tumor vaccine
|
He, Jian
|
|
|
|
7 |
p. 3177-3186
|
artikel
|
| 44 |
Ginsenosides in Panax genus and their biosynthesis
|
Hou, Maoqi
|
|
|
|
7 |
p. 1813-1834
|
artikel
|
| 45 |
Glutamate-releasing BEST1 channel is a new target for neuroprotection against ischemic stroke with wide time window
|
Xiong, Shuai
|
|
|
|
7 |
p. 3008-3026
|
artikel
|
| 46 |
Gold nanoparticle-directed autophagy intervention for antitumor immunotherapy via inhibiting tumor-associated macrophage M2 polarization
|
Zhang, Siyue
|
|
|
|
7 |
p. 3124-3138
|
artikel
|
| 47 |
Gold nanorods-mediated efficient synergistic immunotherapy for detection and inhibition of postoperative tumor recurrence
|
Zhang, Yingying
|
|
|
|
7 |
p. 1978-1992
|
artikel
|
| 48 |
GPRC5B protects osteoarthritis by regulation of autophagy signaling
|
He, Liang
|
|
|
|
7 |
p. 2976-2989
|
artikel
|
| 49 |
Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight
|
He, Chunting
|
|
|
|
7 |
p. 1175-1191
|
artikel
|
| 50 |
Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants
|
Tu, Bin
|
|
|
|
7 |
p. 3187-3194
|
artikel
|
| 51 |
Inhibition of LIM kinase reduces contraction and proliferation in bladder smooth muscle
|
Yu, Qingfeng
|
|
|
|
7 |
p. 1914-1930
|
artikel
|
| 52 |
In situ triggering antitumor efficacy of alcohol-abuse drug disulfiram through Cu-based metal-organic framework nanoparticles
|
Hou, Lin
|
|
|
|
7 |
p. 2016-2030
|
artikel
|
| 53 |
Intranasal temperature-sensitive hydrogels of cannabidiol inclusion complex for the treatment of post-traumatic stress disorder
|
Pang, Lulu
|
|
|
|
7 |
p. 2031-2047
|
artikel
|
| 54 |
Isotoosendanin exerts inhibition on triple-negative breast cancer through abrogating TGF-β-induced epithelial–mesenchymal transition via directly targeting TGFβR1
|
Zhang, Jingnan
|
|
|
|
7 |
p. 2990-3007
|
artikel
|
| 55 |
Letter to the editor: Anti-RAS drugs and SARS-CoV-2 infection
|
Bian, Jingwei
|
|
|
|
7 |
p. 1251-1252
|
artikel
|
| 56 |
Letter to the editor: Comment on GLP-1-based drugs and COVID-19 treatment
|
Jin, Tianru
|
|
|
|
7 |
p. 1249-1250
|
artikel
|
| 57 |
Metabolic engineering of yeasts for green and sustainable production of bioactive ginsenosides F2 and 3β,20S-Di-O-Glc-DM
|
Jiang, Fenglin
|
|
|
|
7 |
p. 3167-3176
|
artikel
|
| 58 |
Molecularly engineered truncated tissue factor with therapeutic aptamers for tumor-targeted delivery and vascular infarction
|
Li, Bozhao
|
|
|
|
7 |
p. 2059-2069
|
artikel
|
| 59 |
mRNA cancer vaccines: Advances, trends and challenges
|
He, Qing
|
|
|
|
7 |
p. 2969-2989
|
artikel
|
| 60 |
Mucosal delivery of nanovaccine strategy against COVID-19 and its variants
|
Lee, Junwoo
|
|
|
|
7 |
p. 2897-2925
|
artikel
|
| 61 |
Natural compounds modulate the autophagy with potential implication of stroke
|
Ahsan, Anil
|
|
|
|
7 |
p. 1708-1720
|
artikel
|
| 62 |
Newly developed gas-assisted sonodynamic therapy in cancer treatment
|
Pan, Meng
|
|
|
|
7 |
p. 2926-2954
|
artikel
|
| 63 |
Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope
|
Ma, Sinan
|
|
|
|
7 |
p. 2990-3005
|
artikel
|
| 64 |
Novel approach for real-time monitoring of carrier-based DPIs delivery process via pulmonary route based on modular modified Sympatec HELOS
|
Zhang, Xuejuan
|
|
|
|
7 |
p. 1331-1346
|
artikel
|
| 65 |
Oral nano-formulation improves pancreatic islets dysfunction via lymphatic transport for antidiabetic treatment
|
Hou, Lin
|
|
|
|
7 |
p. 3137-3152
|
artikel
|
| 66 |
Peripheral origin exosomal microRNAs aggravate glymphatic system dysfunction in diabetic cognitive impairment
|
Zhang, Lin
|
|
|
|
7 |
p. 2817-2825
|
artikel
|
| 67 |
Pharmacologically targeting molecular motor promotes mitochondrial fission for anti-cancer
|
Qian, Yi
|
|
|
|
7 |
p. 1853-1866
|
artikel
|
| 68 |
Phototriggered structures: Latest advances in biomedical applications
|
Shamsipur, Mojtaba
|
|
|
|
7 |
p. 2844-2876
|
artikel
|
| 69 |
Picomolar inhibitor of reverse transcriptase featuring significantly improved metabolic stability
|
Sang, Ya-Li
|
|
|
|
7 |
p. 3054-3066
|
artikel
|
| 70 |
Polyoxypregnanes as safe, potent, and specific ABCB1-inhibitory pro-drugs to overcome multidrug resistance in cancer chemotherapy in vitro and in vivo
|
Wu, Xu
|
|
|
|
7 |
p. 1885-1902
|
artikel
|
| 71 |
Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
|
Liu, Xiaoyan
|
|
|
|
7 |
p. 1205-1215
|
artikel
|
| 72 |
Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models
|
Yu, Ziru
|
|
|
|
7 |
p. 1903-1913
|
artikel
|
| 73 |
Pure redox-sensitive paclitaxel–maleimide prodrug nanoparticles: Endogenous albumin-induced size switching and improved antitumor efficiency
|
Lou, Xinyu
|
|
|
|
7 |
p. 2048-2058
|
artikel
|
| 74 |
Recent advances in nanomedicines for the treatment of ischemic stroke
|
Li, Chao
|
|
|
|
7 |
p. 1767-1788
|
artikel
|
| 75 |
Repurposing econazole as a pharmacological autophagy inhibitor to treat pancreatic ductal adenocarcinoma
|
Weng, Ningna
|
|
|
|
7 |
p. 3085-3102
|
artikel
|
| 76 |
Reversing the PAI-1-induced fibrotic immune exclusion of solid tumor by multivalent CXCR4 antagonistic nano-permeator
|
Dong, Jingwen
|
|
|
|
7 |
p. 3106-3120
|
artikel
|
| 77 |
SARS-CoV-2 spike host cell surface exposure promoted by a COPI sorting inhibitor
|
Li, Yiqun
|
|
|
|
7 |
p. 3043-3053
|
artikel
|
| 78 |
Screening potential P-glycoprotein inhibitors by combination of a detergent-free membrane protein extraction with surface plasmon resonance biosensor
|
Cao, Yuhong
|
|
|
|
7 |
p. 3113-3123
|
artikel
|
| 79 |
Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives
|
Fang, Yuan
|
|
|
|
7 |
p. 1253-1278
|
artikel
|
| 80 |
Structure-based discovery of orally efficient inhibitors via unique interactions with H-pocket of PDE8 for the treatment of vascular dementia
|
Wu, Xu-Nian
|
|
|
|
7 |
p. 3103-3112
|
artikel
|
| 81 |
Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy
|
Yu, Ling
|
|
|
|
7 |
p. 2004-2015
|
artikel
|
| 82 |
Table of Contents
|
|
|
|
|
7 |
p. iii-viii
|
artikel
|
| 83 |
Table of Contents
|
|
|
|
|
7 |
p. iii-ix
|
artikel
|
| 84 |
Table of Contents
|
|
|
|
|
7 |
p. iii-viii
|
artikel
|
| 85 |
Table of Contents
|
|
|
|
|
7 |
p. iii-ix
|
artikel
|
| 86 |
Target-based anticancer indole derivatives and insight into structure‒activity relationship: A mechanistic review update (2018–2021)
|
Dhiman, Ashima
|
|
|
|
7 |
p. 3006-3027
|
artikel
|
| 87 |
Targeted inhibition of GRK2 kinase domain by CP-25 to reverse fibroblast-like synoviocytes dysfunction and improve collagen-induced arthritis in rats
|
Han, Chenchen
|
|
|
|
7 |
p. 1835-1852
|
artikel
|
| 88 |
Targeting macrophagic SHP2 for ameliorating osteoarthritis via TLR signaling
|
Sun, Ziying
|
|
|
|
7 |
p. 3073-3084
|
artikel
|
| 89 |
The cellular immunotherapy of integrated photothermal anti-oxidation Pd–Se nanoparticles in inhibition of the macrophage inflammatory response in rheumatoid arthritis
|
Zheng, Chuping
|
|
|
|
7 |
p. 1993-2003
|
artikel
|
| 90 |
The chromosome-level reference genome assembly for Dendrobium officinale and its utility of functional genomics research and molecular breeding study
|
Niu, Zhitao
|
|
|
|
7 |
p. 2080-2092
|
artikel
|
| 91 |
The influence of the gut microbiota on the bioavailability of oral drugs
|
Zhang, Xintong
|
|
|
|
7 |
p. 1789-1812
|
artikel
|
| 92 |
The phytochemical, biological, and medicinal attributes of phytoecdysteroids: An updated review
|
Das, Niranjan
|
|
|
|
7 |
p. 1740-1766
|
artikel
|
| 93 |
Viral miRNA-mediated activation of hyaluronan production as a drug target against COVID-19
|
Yang, Shuai
|
|
|
|
7 |
p. 3195-3197
|
artikel
|
| 94 |
Why 90% of clinical drug development fails and how to improve it?
|
Sun, Duxin
|
|
|
|
7 |
p. 3049-3062
|
artikel
|
Tijdschrift beschrijving